Search

Objective: Influenza and pneumococcal vaccines are recommended for chronic obstructive pulmonary disease (COPD) cases in national and international guidelines. In this study, it was aimed to determine the vaccination rates for influenza and pneumococcal diseases in COPD patients and to determine the demographic and clinical, characteristics that affect the vaccination of the patients. Methods: Our study included 297 COPD patients aged 18 years and older who were diagnosed with COPD for at least 1 year according to the Global Initiative for Chronic Obstructive Lung Disease criteria. Pulmonary function tests of the patients, staging of the disease, and the Modified Medical Research Council scale were recorded. Results: When the 297 patients included in the study were evaluated according to the inclusion and exclusion criteria. In the study, the rate of influenza vaccination in COPD patients in the last year was 29.4% and the rate of pneumococcal vaccination at least once in their lifetime was 34.5%. Vaccination rates of patients aged 65 and over were significantly higher in influenza vaccination (p=0.036). In pneumococcal vaccination, the vaccination rate was statistically high in those with a high education level (p=0.001). It was observed that the vaccination rates were significantly lower in patients with low-income levels in both vaccine groups (p=0.044, p=0.034). When asked about the reason for the unvaccinated patients, they were told that they were not aware of the vaccine (41.3%, 76.0%) in the first place and that their doctor did not recommend it (28.2%, 27.6%) in the second place for influenza and pneumococcal vaccines. Conclusion: Influenza and pneumococcal vaccine application rates in patients with COPD were found to be low in our country, in line with the literature. The lack of doctor's advice and lack of knowledge about the vaccine was important factors in unvaccinated individuals. [ABSTRACT FROM AUTHOR]